When does Addex report earnings and why does it matter for ADXN.SW stock

Addex reports on 09 Mar 2026. The update matters because Addex is development-stage and earnings will stress cash runway and clinical timelines, which directly affect ADXN.SW stock volatility and valuation.

What is Meyka AI's forecast for ADXN.SW stock and the implied move

Meyka AI's forecast model projects **CHF 0.03** for one year, implying **-40.00%** versus the current **CHF 0.05**. Forecasts are model projections and not guarantees.

What are the main catalysts to watch in the earnings report for ADXN.SW stock

Investors should watch cash balance, milestone payments, Dipraglurant development updates, and any partnership news. Positive timing or payments would be the clearest catalysts for ADXN.SW stock.

How liquid is ADXN.SW stock and what technical signs matter

Average volume is **174463.00** with recent volume **199946.00**, so liquidity is limited versus large caps. RSI **34.97** signals near-oversold conditions. Low liquidity can magnify price moves.

CH Stocks

ADXN.SW Addex Therapeutics (SIX) earnings due 06 Mar 2026: catalysts and outlook

ByDanny Kontos March 7, 2026

Addex Therapeutics (ADXN.SW) trades at CHF 0.05 as we head into its earnings announcement on 09 Mar 2026. ADXN.SW stock rose 8.70% on volume 199946.00 in the latest session, with the market closed on our reporting day, 06 Mar 2026. We expect the report to focus on cash runway, clinical updates for Dipraglurant, and partner milestone timing. This earnings spotlight frames valuation, pipeline catalysts, and short-term trading risk for Swiss-listed Addex on the SIX exchange.